An epidemiological study determining blood pressure in a Portuguese cohort: The Guimarães/Vizela study

Journal of Human Hypertension

Volumn 29, Issue 3, 2015, Pages 190-197

  Cunha, P G ^a,b   Cotter, J ^a,b   Oliveira, P ^c   Vila, I ^a   Sousa, N ^b  

^a Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE SURVEILLANCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PREHYPERTENSION; PREVALENCE; SEX DIFFERENCE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PORTUGAL; PREHYPERTENSION;

EID: 84926154034     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.61     Document Type: Article

References (39)

1. Crim MT, Yoon SS, Ortiz E, Wall HK, Schober S, Gillespie C et al. National surveillance definitions for hypertension prevalence and control among adults. Circ Cardiovasc Qual Outcomes 2012; 5(3): 343-351.
2. Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014; 92(1): 10-9C.
3. Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003; 21(3): 509-517.
4. Modesti PA, Rapi S, Bamoshmoosh M, Baldereschi M, Massetti L, Padeletti L et al. Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. BMJ Open 2012; 2(4): e001062.
5. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22(1): 11-19.
6. Figueiredo D, Azevedo A, Pereira M, de Barros H. Definition of hypertension: the impact of number of visits for blood pressure measurement. Rev Port Cardiol 2009; 28(7-8): 775-783.
7. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27(5): 963-975.
8. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375(9718): 895-905.
9. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 2005; 23(9): 1661-1666.
10. Cortez-Dias N, Martins S, Belo A, Fiuza M. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Rev Port Cardiol 2009; 28(5): 499-523.
11. Pereira M, Carreira H, Vales C, Rocha V, Azevedo A, Lunet N. Trends in hypertension prevalence (1990-2005) and mean blood pressure (1975-2005) in Portugal: a systematic review. Blood Press 2012; 21(4): 220-226.
12. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377(9765): 568-577.
13. CunhaPG CJ, Oliveira P, Vila I, Sousa N. The rational/design of the Guimarães/Vizela study: a multimodal population based cohort study to determine global cardiovascular risk and disease. J Investig Med 2014; 62(5): 813-820.
14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-1187.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-1252.
16. De Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal. The PAP study. Rev Port Cardiol 2007; 26(1): 21-39.
17. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012; 60(7): 599-606.
18. Scuteri A, Najjar SS, Orru M, Albai G, Strait J, Tarasov KV et al. Age-and genderspecific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Nutr Metab Cardiovasc Dis 2009; 19(8): 532-541.
19. Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechere-Bertschi A. 1999-2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS ONE 2012; 7(6): e39877.
20. Huerta JM, Tormo MJ, Gavrila D, Navarro C. Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with highprevalence of cardiovascular risk factors. BMC Public Health 2010; 10: 640.
21. Ortiz Marron H, Vaamonde Martin RJ, Zorrilla Torras B, Arrieta Blanco F, Casado Lopez M, Medrano Albero MJ. [Prevalence, degree of control and treatment of hypertension in the adult population of Madrid, Spain]. Rev Esp Salud Publica 2011; 85(4): 329-338.
22. Perez-Fernandez R, Marino AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I et al. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens 2007; 21(5): 366-373.
23. Felix-Redondo FJ, Fernandez-Berges D, Fernando Perez J, Zaro MJ, Garcia A, Lozano L et al. [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study]. Aten Primaria 2011; 43(8): 426-434.
24. Hernandez-Hernandez R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens 2010; 28(1): 24-34.
25. Nichols MTN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 2012. Brussels, Belgium, 2012.
26. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224-2260.
27. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913.
28. Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A et al. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens 2013; 26(1): 83-94.
29. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30(6): 1065-1074.
30. Cifkova R, Skodova Z, Bruthans J, Holub J, Adamkova V, Jozifova M et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 2010; 28(11): 2196-2203.
31. Efstratopoulos AD, Voyaki SM, Baltas AA, Vratsistas FA, Kirlas DE, Kontoyannis JT et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19(1): 53-60.
32. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53(3): 480-486.
33. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358(9294): 1682-1686.
34. Zhang H, Thijs L, Kuznetsova T, Fagard RH, Li X, Staessen JA. Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes. J Hypertens 2006; 24(9): 1719-1727.
35. Markus MR, Stritzke J, Lieb W, Mayer B, Luchner A, Doring A et al. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: the MONICA/KORA Augsburg study. J Hypertens 2008; 26 (10): 2040-2049.
36. Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y et al. Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study. J Hypertens 2012; 30(5): 893-900.
37. Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation 2008; 118(15): 1577-1584.
38. Lee M, Saver JL, Chang B, Chang KH, Hao Q, Ovbiagele B. Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology 2011; 77 (14): 1330-1337.
39. Kanno A, Kikuya M, Ohkubo T, Hashimoto T, Satoh M, Hirose T et al. Prehypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant 2012; 27(8): 3218-3223.